Abstract

Introduction: cFLIP is a major anti-apoptotic protein that blocks the apoptotic pathway mediated by death receptors. It is overexpressed in many cancers resulting in chemoresistance and limiting the effectiveness of commonly used anticancer therapies. Both the long (FLIPL) and the short (FLIPS) splice forms compete with procaspase 8 for binding with the adaptor protein FADD at the death inducing signaling complex (DISC), which is formed after stimulation of death receptors by their ligands. Materials and Methods:Molecular modeling of the FLIP–FADD interaction was performed using published structures viral FLIP (MC159) and human FADD. Site directed mutagenesis of was performed to study the importance of specific residues of FLIP. Protein–protein interactions were studied by GST-pulldown assay. DISC recruitment of FLIP mutants was investigated in a DISC IP assay. Western blotting was performed to assess protein levels. Results: Modelling identified several key residues which appeared to be important for the cFLIP–FADD interaction. Site directed mutagenesis was performed against these key residues, and a panel of cFLIP and FADD mutants was generated. These mutants were then screened for their ability to interact with either FADD or cFLIP using GST-pulldown assays. A functional assay for DISC recruitment was also carried out to confirm which of these mutations resulted in impaired recruitment. This analysis established the critical amino acids which mediate DED interactions between cFLIP and FADD. Conclusions: Iterative rounds of computer modelling and mutagenesis have characterised the molecular features of the interaction between the pro-apoptotic adaptor molecule FADD and the anti-apoptotic protein FLIP.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.